Search results
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 5 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
The Unexpectedly Good News That Helped Regeneron Retake Its 200-Day Line
Investor's Business Daily· 9 months agoRegeneron Pharmaceuticals predicted a faster-than-expected approval timeline for a high dose of its...
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
Benzinga via Yahoo Finance· 1 year agoThe UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related...
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success
BioPharma Dive via Yahoo Finance· 5 months agoResults from the second of two Phase 3 trials testing the blockbuster drug in the respiratory...
3 Magnificent Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 3 months agoTime in the market beats timing the market, hands-down. But how long should you own a stock? Famed investor Warren Buffett perhaps said it best: "When we...
Is Sanofi on the Verge of Another Blockbuster?
Motley Fool· 2 years agoThe U.S. Food and Drug Administration (FDA) recently announced that it had accepted Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) supplemental...
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
Investor's Business Daily· 2 years agoA cure for genetic diseases has been little more than a whisper — until now. Thanks to the work of...
A day of life and death in a COVID hotspot: Jacksonville
The Florida Times-Union via Yahoo News· 2 years agoShortly before noon on Friday, Jacquelyn Graham-Townes leaned over a white casket containing another...
Roche reports survival data for new dual-acting lymphoma drug
BioPharma Dive via Yahoo Finance· 2 weeks agoDive Brief: Roche’s new dual-acting blood cancer drug Columvi combined with chemotherapy helped...
